Table 5: Characteristics related to dosage of anesthetic agents in oncological patients undergoing general anesthesia at FCECON for surgical procedures.
|
Characteristics |
n (119) |
% |
|
Rocuronium Dosage |
|
|
|
30 to 50 mg |
91 |
76.5 |
|
60 to 80 mg |
21 |
17.6 |
|
> 80 mg |
7 |
5.9 |
|
Use of Interfering Drugs |
|
|
|
Yes |
0 |
0.0 |
|
No |
119 |
100.0 |
|
Sugammadex Dosage |
|
|
|
50 to 110 mg |
15 |
12.6 |
|
120 to 160 mg |
45 |
37.8 |
|
> 160 mg |
59 |
49.6 |
|
TOF Assessment Period in PACU |
|
|
|
30 minutes to 1 hour |
61 |
51.3 |
|
1 hour 01 minute to 2 hours |
44 |
37.0 |
|
2 hours 01 minutes to 4 hours |
14 |
11.8 |
|
Residual Neuromuscular Blockade (RNMB) |
|
|
|
Yes |
5 |
4.2 |
|
No |
114 |
95.8 |
|
Complications due to RNMB |
|
|
|
Yes (TOF T4/T1 < 0.7) |
1 |
0.8 |
|
No |
118 |
99.2 |